GENTA INCORPORATED /DE/
4/A, 1998-11-12
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: GENTA INCORPORATED /DE/, 4/A, 1998-11-12
Next: MONEY STORE D C INC, 8-K, 1998-11-12




                UNITED STATES SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549

                                     FORM 4
                                   
                  STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

[ ] Check this box if no longer subject to Section 16.
Form 4 or Form 5 obligations may continue. See Instructions 1(b).


1. Name and Address of Reporting Person

David R. Walner
c/o Paramount Capital, Inc.
787 Seventh Avenue, 48th Floor
New York, New York  10019

2. Issuer Name and Ticker or Trading Symbol

   Genta Incorporated -- GNTA

3. IRS or Social Security Number of Reporting Person (Voluntary)
   
4. Statement for Month/Year

   01/98

5. If Amendment, Date of Original (Month/Year)
   01/16/98

6. Relationship of Reporting Person(s) to Issuer (Check all applicable)
   ( ) Director ( ) 10% Owner ( ) Officer (give title below) (x) Other
   (specify below)

   See Footnote (1)

7. Individual or Joint/Group Filing (Check Applicable Line)

   (x) Form filed by One Reporting Person
   ( ) Form filed by More than One Reporting Person

<TABLE>
<CAPTION>
___________________________________________________________________________________________________________________________________
 Table I -- Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned                                                 |
___________________________________________________________________________________________________________________________________|
1. Title of Security       |2.     |3.    |4.Securities Acquired (A)         |5.Amount of        |6.Dir |7.Nature of Indirect      |
                           | Transaction  |  or Disposed of (D)              |  Securities       |ect   |  Beneficial Ownership    |
                           |       |      |                                  |  Beneficially     |(D)or |                          |
                           |       |    | |                  | A/|           |  Owned at         |Indir |                          |
                           | Date  |Code|V|    Amount        | D |    Price  |  End of Month     |ect(I)|                          |
___________________________________________________________________________________________________________________________________|
<S>                        <C>    <C>  <C><C>               <C> <C>         <C>                 <C>    <C>
- -----------------------------------------------------------------------------------------------------------------------------------|
                           |       |    | |                  |   |           |                   |      |                          |
                           |       |    | |                  |   |           |                   |      |                          |
- -----------------------------------------------------------------------------------------------------------------------------------|
                           |       |    | |                  |   |           |                   |      |                          |
                           |       |    | |                  |   |           |                   |      |                          |
- -----------------------------------------------------------------------------------------------------------------------------------|
                           |       |    | |                  |   |           |                   |      |                          |
                           |       |    | |                  |   |           |                   |      |                          |
- -----------------------------------------------------------------------------------------------------------------------------------|
___________________________________________________________________________________________________________________________________|
<CAPTION>


<PAGE>

___________________________________________________________________________________________________________________________________
 Table II -- Derivative Securitites Acquired, Disposed of, or Beneficially Owned                                                   |
___________________________________________________________________________________________________________________________________|
1.Title of Derivative |2.Con-  |3.   |4.    |5.Number of De |6.Date Exer|7.Title and Amount  |8.Price|9.Number    |10.|11.Nature of|
  Security            |version |Transaction | rivative Secu |cisable and|  of Underlying     |of Deri|of Deriva   |Dir|Indirect    |
                      |or Exer |     |      | rities Acqui  |Expiration |  Securities        |vative |tive        |ect|Beneficial  |
                      |cise    |     |      | red(A) or Dis |Date(Month/|                    |Secu   |Securities  |(D)|Ownership   |
                      |Price of|     |      | posed of(D)   |Day/Year)  |                    |rity   |Benefi      |or |            |
                      |Deriva- |     |      |               |Date |Expir|                    |       |ficially    |Ind|            |
                      |tive    |     |      |       |       |Exer-|ation|   Title and Number |       |Owned at    |ire|            |
                      |Secu-   |     |    | | (A)   | (D)   |cisa-|Date |   of Shares        |       |End of      |ct |            |
                      |rity    |Date |Code|V|       |       |ble  |     |                    |       |Month       |(I)|            |
___________________________________________________________________________________________________________________________________|
<S>                   <C>      <C>   <C>  <C><C>        <C> <C>   <C>   <C>          <C>     <C>     <C>          <C> <C>
Series D Convertible  |$0.94375|12/29|J(2)| |  139  |       |12/31| N/A | Common  | 14,697   | (2)(4)|  (2)(3)    | D |            |
Preferred Stock (2)   |        | /97 | (4)| |       |       | /97 |     |  Stock  |          |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
Class D Warrants (2)  |$0.94375|12/29|J(2)| |  694  |       |12/31|6/30/| Common  |  694     | (2)(4)|  (2)(3)    | D |            |
                      |        | /97 | (4)| |       |       | /97 | 02  | Stock   |          |       |            |   |            |
                      |        |     |    | |       |       |     |     |         |          |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
Series D Convertible  |$0.94375|12/29|J(3)| |  784  |       |12/31| N/A | Common  | 83,047   | (3)(4)|  (2)(3)    | D |            |
Preferred Stock (3)   |        | /97 | (4)| |       |       | /98 |     |  Stock  |          |       |            |   |            |
- -----------------------------------------------------------------------------------------------------------------------------------|
Class D Warrants (3)  |$0.94375|12/29|J(3)| | 3,919 |       |12/31|6/30/| Common  | 3,919    | (3)(4)|  (2)(3)    | D |            |
                      |        | /97 | (4)| |       |       | /98 |  02 |         |          |       |            |   |            |
                      |        |     |    | |       |       |     |     |         |          |       |            |   |            |
___________________________________________________________________________________________________________________________________|

</TABLE>
Explanation of Responses:

(1)  Mr. Walner  disclaims  status as an officer of the Company under Rule 16a-2
     and is making  this filing  voluntarily.  

(2)  These Series D Preferred Stock and Class D Warrants are components of units
     ("Units")  issuable  upon  exercise  of  warrants  ("Placement   Warrants")
     exercisable  from  December 31, 1997 to December  30,  2007,  at an initial
     exercise price of $110,000 per Unit. Each Unit consists,  initially, of (i)
     1,000  shares of Series D Preferred  Stock of the Issuer,  par value $0.001
     per share,  and (ii) 5,000  Class D  Warrants.  Mr.  Walner   may be deemed
     beneficially  to own  Placement  Warrants to purchase an aggregate of .1387
     Units. The Placement Warrants contain certain anti-dilution adjustments.

(3)  These Series D Preferred Stock and Class D Warrants are components of Units
     issuable upon exercise of warrants ("Advisory  Warrants")  exercisable from
     December  31, 1998 to December 30, 2007,  at an initial  exercise  price of
     $110,000 per Unit.  Mr. Walner may be deemed  beneficially  to own Advisory
     Warrants to purchase an aggregate of .78376  Units.  The Advisory  Warrants
     contain certain anti-dilution adjustments.

(4)  On December 29, 1997,  Paramount  Capital Inc.  designated  recipients (the
     "Paramount  Warrant  Designees") of the Placement Warrants and the Advisory
     Warrants. Mr. Walner was among the Paramount Warrant Designees and received
     such Placement  Warrants and Advisory Warrants in connection with a private
     placement  (the "Private  Placement")  of securities of the Issuer of which
     Paramount  Capital,  Inc. acted as placement  agent.  


SIGNATURE OF REPORTING PERSON


/s/ David R. Walner
- --------------------
David R. Walner


DATE:

November 12, 1998    




© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission